ArticleBiomedicines2021

A Comparison between Endostatin and Conventional Biomarkers on 30-Day Mortality and Renal Replacement Therapy in Unselected Intensive Care Patients.

Toralph Ruge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.